Self-assembled polymeric nanoparticle of PEGylated chitosan–ceramide conjugate for systemic delivery of paclitaxel

References

• Yoo JW, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliv Rev 2011;63:1247–56
   PubMed Web of Science ®Google Scholar
• Kedar U, Phutane P, Shidhaye S, et al. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 2010;6:714–29
   PubMed Web of Science ®Google Scholar
• Siddiqui IA, Adhami VM, Chamcheu JC, et al. Impact of nanotechnology in cancer: emphasis on nanochemoprevention. Int J Nanomed 2012;7:591–605
   PubMed Web of Science ®Google Scholar
• Zhang L, Gu FX, Chan JM, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008;83:761–9
   PubMed Web of Science ®Google Scholar
• Gamboa JM, Leong KW. In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv Drug Deliv Rev 2013;65:800–10
   PubMed Web of Science ®Google Scholar
• Thanou MM, Kotze AF, Scharringhausen T, et al. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers. J Control Release 2000;64:15–25
   PubMed Web of Science ®Google Scholar
• Chen MC, Mi FL, Liao ZX, et al. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Deliv Rev 2013;65:865–79
   PubMed Web of Science ®Google Scholar
• Leong KW, Sung HW. Nanoparticle- and biomaterials-mediated oral delivery for drug, gene, and immunotherapy. Adv Drug Deliv Rev 2013;65:757–8
   PubMed Web of Science ®Google Scholar
• Jang MK, Jeong YI, Nah JW. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug. Colloids Surf B Biointerfaces 2010;81:530–6
   PubMed Web of Science ®Google Scholar
• Kim K, Kwon S, Park JH, et al. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 2005;6:1154–8
   PubMed Web of Science ®Google Scholar
• Liu CG, Desai KG, Chen XG, et al. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles. J Agric Food Chem 2005;53:437–41
   PubMed Web of Science ®Google Scholar
• Chen XG, Lee CM, Park HJ. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acid-modified chitosan in the aqueous system. J Agric Food Chem 2003;51:3135–9
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen XG, Li YY, et al. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomedicine 2007;3:258–65
   PubMed Web of Science ®Google Scholar
• Wang XY, Zhang L, Wei XH, et al. Molecular dynamics of paclitaxel encapsulated by salicylic acid-grafted chitosan oligosaccharide aggregates. Biomaterials 2013;34:1843–51
   PubMed Web of Science ®Google Scholar
• Kim S, Shi Y, Kim JY, et al. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Deliv 2010;7:49–62
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, et al. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 2008;60:1650–62
   PubMed Web of Science ®Google Scholar
• Battogtokh G, Ko YT. Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of Paclitaxel. Pharm Res 2014. [Epub ahead of print]. doi: 10.1007/s11095-014-1395-2
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007;24:1–16
   PubMed Web of Science ®Google Scholar
• Koshkaryev A, Sawant R, Deshpande M, et al. Immunoconjugates and long circulating systems: origins, current state of the art and future directions. Adv Drug Deliv Rev 2013;65:24–35
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Passive and active drug targeting: drug delivery to tumors as an example. Handb Exp Pharmacol 2010;197:3–53
   PubMedGoogle Scholar
• Couvreur P. Nanoparticles in drug delivery: past, present and future. Adv Drug Deliver Rev 2013;65:21–23
   PubMed Web of Science ®Google Scholar
• Abuchowski A, Kazo GM, Verhoest CR, Jr., et al. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem Biophys 1984;7:175–86
   PubMedGoogle Scholar
• Riviere K, Huang Z, Jerger K, et al. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration. J Drug Target 2011;19:14–24
   PubMed Web of Science ®Google Scholar
• Lee CM, Jang D, Kim J, et al. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo. Bioconjug Chem 2011;22:186–92
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon HY, Koo H, et al. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic(R) for tumor-targeted delivery of docetaxel. Biomaterials 2011;32:7181–90
   PubMed Web of Science ®Google Scholar
• Zhao T, Chen H, Dong Y, et al. Paclitaxel-loaded poly(glycolide-co-epsilon-caprolactone)-b-D-alpha-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Int J Nanomed 2013;8:1947–57
   PubMed Web of Science ®Google Scholar
• Battogtokh G, Liu HB, Bae SM, et al. Synthesis of chlorin-based unsaturated fatty acid conjugates: their in vitro phototoxicity on TC-1 cancer cell line. J Photochem Photobiol B 2012;110:50–7
   PubMed Web of Science ®Google Scholar
• Xue Y, Tang X, Huang J, et al. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-alpha, beta-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Colloids Surf B Biointerfaces 2011;85:280–8
   PubMed Web of Science ®Google Scholar
• Patel MP, Patel RR, Patel JK. Chitosan mediated targeted drug delivery system: a review. J Pharm Pharm Sci 2010;13:536–57
   PubMed Web of Science ®Google Scholar
• Aktas Y, Yemisci M, Andrieux K, et al. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 2005;16:1503–11
   PubMed Web of Science ®Google Scholar
• Wang F, Li X, Zhou Y, et al. Nanoscaled polyion complex micelles for targeted delivery of recombinant hirudin to platelets based on cationic copolymer. Mol Pharm 2010;7:718–26
   PubMed Web of Science ®Google Scholar
• Ferrari R, Colombo C, Casali C, et al. Synthesis of surfactant free PCL-PEG brushed nanoparticles with tunable degradation kinetics. Int J Pharm 2013;453:551–9
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol 2011;670:372–83
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Opanasopit P, Okano T, et al. Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J Drug Target 2004;12:373–84
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, Cremophor EL. The drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590–8
   PubMed Web of Science ®Google Scholar
• Lv PP, Ma YF, Yu R, et al. Targeted delivery of insoluble cargo (paclitaxel) by PEGylated chitosan nanoparticles grafted with Arg-Gly-Asp (RGD). Mol Pharm 2012;9:1736–47
   PubMed Web of Science ®Google Scholar